Immune mediated colitis caused by lung cancer treatment with atezolizumab. [electronic resource]
Producer: 20180815Description: 863-864 p. digitalISSN:- 1130-0108
- Adult
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- complications
- Colitis -- chemically induced
- Humans
- Lung Neoplasms -- complications
- Male
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.